StonvexLoading…
StonvexStonvexStonvexCore line items from MTZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.83B | $14.30B | $10.36B | $6.39B |
Operating Income | $141.80M | $515.40M | $341.36M | $129.74M |
Net Income | $60.84M | $399.04M | $256.33M | $95.67M |
EPS (Diluted) | $0.77 | $5.07 | $3.26 | $1.21 |
Total Assets | $10.44B | $9.92B | $9.69B | $9.13B |
Total Liabilities | $7.01B | $6.59B | $6.51B | $6.12B |
Cash & Equivalents | $273.67M | $396.03M | $231.42M | $191.05M |
Free Cash Flow OCF − CapEx | $2.09M | $285.73M | $-6.79M | $-27.07M |
Shares Outstanding | 78.78M | 78.69M | 78.67M | 78.75M |